Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
11,823,764
-
Total 13F shares
-
5,909,706
-
Share change
-
+781,679
-
Total reported value
-
$133,205,244
-
Price per share
-
$22.54
-
Number of holders
-
64
-
Value change
-
+$16,635,081
-
Number of buys
-
43
-
Number of sells
-
11
Institutional Holders of PALVELLA THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PVLA) as of Q2 2025
As of 30 Jun 2025,
PALVELLA THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PVLA) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,909,706 shares.
The largest 10 holders included
Frazier Life Sciences Management, L.P., SUVRETTA CAPITAL MANAGEMENT, LLC, BVF INC/IL, Woodline Partners LP, BlackRock, Inc., SAMSARA BIOCAPITAL, LLC, MILLENNIUM MANAGEMENT LLC, ADAMS STREET PARTNERS LLC, Nantahala Capital Management, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
64
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.